ロード中...
Nicotinamide Supplementation Attenuates Renal Interstitial Fibrosis via Boosting the Activity of Sirtuins
BACKGROUND: Progressive tubulointerstitial fibrosis (TIF) is the final common pathway leading to ESRD. There is an urgent need to develop effective approaches slowing the progression of TIF. Previous studies showed that systemic supplementation of nicotinamide (NAM) increases renal NAD<sup>+&l...
保存先:
| 出版年: | Kidney Dis (Basel) |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
S. Karger AG
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8216029/ https://ncbi.nlm.nih.gov/pubmed/34179114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000510943 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|